FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible ...

The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Devices and Getinge have recently announced their partnership under which they will integrate Getinge’s bioreactors with 908 ...

The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...

The Food and Drug Administration is warning that critical alerts from diabetes devices may fail to reach users, risking ...

U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor ...

Glucose monitoring has evolved beyond its traditional role in diabetes management, with an increasing number of people using ...

Living with Type 1 diabetes is a numbers game. There’s not a moment in the day free from the burden of tracking your blood ...

The network monitoring market is projected to reach $4.2 billion by 2032, at a CAGR of 7.6% during the forecast period 2025–2032. Download FREE PDF Brochure Of Network Monitoring Market - ...